|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.10 EUR | +0.82% |
|
0.00% | -9.80% |
| 06-25 | Germany's Merck boosts life sciences business with $11 billion bet on Bio-Techne | RE |
| 06-25 | US prices for new drugs fell in 2025 as fewer costly gene therapies were launched | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1,006B | |||||
| 589B | |||||
| 430B | |||||
| 331B | |||||
| 288B |
- Stock Market
- Stocks
- SAN Stock
- SNW2 Stock
- Charts Sanofi
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
